The Danish pharma company Novo Nordisk and the US AI company Nvidia announced their plans to build a supercomputer in Healthcare in March 18th.
The aim is to make one of the world’s most powerful AI supercomputer for the pharma research, green transition and drug innovation. The AI innovation center will be in Denmark.
According to the release some piloting projects are made already this year and next year the installations should be ready.
Novo Nordisk is on the way to innovate new drugs to heart diseases, diabetes, obesity, some cancer types and the newest ones: Parkinson and Alzheimer diseases.
According to latest research related to Parkinson disease, Novo could find the new drug composition to it during the next two years.
The company has lately invested to its obesity and diabetes drug manufacturing in the US and bought a cardiovascular company Cardior Pharmaceuticals from the US.
ComteamPUB+ 